Xvivo Perfusion AB(GB:0RKL)
kr 206.00+3.60 (+1.78%)
GB:0RKL
Xvivo Perfusion AB financials statements
kr 206.00
At close:+3.60 (+1.78%)
Xvivo Perfusion AB (0RKL) Income Statement
0 Followers
Xvivo Perfusion AB Income Statement
Last quarter (Q3 2026), Xvivo Perfusion AB's total revenue was kr252.56M, an increase of 33.53% from the same quarter last year. In Q3, Xvivo Perfusion AB's net income was kr44.62M. See Xvivo Perfusion AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 812.16M | kr 822.41M | kr 597.54M | kr 415.29M | kr 258.39M | |
| kr 533.50M | kr 616.41M | kr 445.11M | kr 296.96M | kr 188.28M | |
| kr 440.48M | kr 528.06M | kr 440.92M | kr 292.50M | kr 207.02M | |
| Depreciation and Amortization | kr 70.21M | kr 67.42M | kr 30.86M | kr 42.17M | kr 32.26M |
| kr 153.14M | kr 272.97M | kr 35.05M | kr 65.58M | kr 39.20M | |
| kr 93.02M | kr 88.35M | kr 4.19M | kr 23.18M | kr 6.98M | |
| kr -54.46M | kr 111.59M | kr 90.33M | kr -867.00K | kr -317.00K | |
| kr 38.56M | kr 199.95M | kr 94.52M | kr 22.31M | kr 6.67M | |
| kr 25.16M | kr 172.18M | kr 91.82M | kr 18.43M | kr 8.15M | |
| Per Share Metrics | |||||
| Basic EPS | kr 0.80 | kr 5.47 | kr 3.07 | kr 0.62 | kr 0.28 |
| Diluted EPS | kr 0.80 | kr 5.44 | kr 3.07 | kr 0.62 | kr 0.28 |
| Weighted Average Shares Outstanding | 31.50M | 31.50M | 29.94M | 29.53M | 28.85M |
| Weighted Average Shares Outstanding (Diluted) | 31.56M | 31.67M | 29.94M | 29.53M | 28.94M |
Currency in SEK
